Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome

By Gottschalck Ida   Jeppesen Palle   Hartmann Bolette   Holst Jens   Henriksen Dennis  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 11, 2008-01 ,pp. : 1304-1310

Informa Healthcare

Access to resources Recommend Favorite

Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate

By Holst Jens J.   Hartmann Bolette   Gottschalck Ida B.   Jeppesen Palle B.   Miholic Johannes   Henriksen Dennis Bang  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 7, 2007-01 ,pp. : 814-820

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-like Peptide 2

By Drucker D.J.  

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 4, 1999-05 ,pp. : 153-156

Elsevier

Access to resources Recommend Favorite

Short-term Administration of Glucagon-like Peptide-2. Effects on Bone Mineral Density and Markers of Bone Turnover in Short-Bowel Patients with No Colon

By Haderslev K. V.   Jeppesen P. B.   Hartmann B.   Thulesen J.   Sorensen H. A.   Graff J.   Hansen B. S.   Tofteng F.   Poulsen S. S.   Madsen J. L.   Holst J. J.   Staun M.   Mortensen P. B.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 4, 2002-04 ,pp. : 392-398

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1

By Nagell C. F.   Wettergren A.   Pedersen J. F.   Mortensen D.   Holst J. J.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 353-358

Informa Healthcare

Access to resources Recommend Favorite